Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
25
NNOX Quote, Financials, Valuation and Earnings
Last price:
$2.87
Seasonality move
:
-8.71%
Day range:
$2.83 - $2.95
52-week range:
$2.78 - $11.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
14.66x
P/B ratio:
1.19x
Volume:
1.5M
Avg. volume:
2.2M
1-year change:
-62.02%
Market cap:
$187M
Revenue:
$11.3M
EPS (TTM):
-$0.88
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
NNOX
Nano-X Imaging Ltd.
|
$5M | -$0.14 | 33.13% | -35.84% | $8.15 |
|
ICCM
IceCure Medical Ltd.
|
$2.2M | -$0.04 | 2.97% | -49.43% | $3.13 |
|
INBS
Intelligent Bio Solutions, Inc.
|
$1.4M | -- | 160.36% | -- | -- |
|
LAB
Standard BioTools, Inc.
|
$18.6M | -$0.02 | -60.4% | -72.53% | $1.65 |
|
LNSR
LENSAR, Inc.
|
$18.6M | -$0.09 | 30.98% | -90.51% | $15.00 |
|
XYLO
Xylo Technologies Ltd.
|
-- | -- | -- | -- | $9.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
NNOX
Nano-X Imaging Ltd.
|
$2.86 | $8.15 | $187M | -- | $0.00 | 0% | 14.66x |
|
ICCM
IceCure Medical Ltd.
|
$0.66 | $3.13 | $45.8M | -- | $0.00 | 0% | 13.44x |
|
INBS
Intelligent Bio Solutions, Inc.
|
$4.84 | -- | $4.6M | -- | $0.00 | 0% | 9.62x |
|
LAB
Standard BioTools, Inc.
|
$1.38 | $1.65 | $530.7M | -- | $0.00 | 0% | 4.06x |
|
LNSR
LENSAR, Inc.
|
$11.95 | $15.00 | $142.7M | -- | $0.00 | 0% | 2.39x |
|
XYLO
Xylo Technologies Ltd.
|
$5.07 | $9.00 | $6.5M | -- | $3.94 | 0% | 0.13x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
NNOX
Nano-X Imaging Ltd.
|
4.79% | 0.676 | 3.26% | 3.82x |
|
ICCM
IceCure Medical Ltd.
|
3% | -1.540 | 0.41% | 1.76x |
|
INBS
Intelligent Bio Solutions, Inc.
|
35.02% | 2.804 | 21.48% | 0.47x |
|
LAB
Standard BioTools, Inc.
|
6.41% | 0.589 | 5.49% | 1.93x |
|
LNSR
LENSAR, Inc.
|
-31.16% | -1.208 | 1.79% | 0.65x |
|
XYLO
Xylo Technologies Ltd.
|
29.91% | -0.433 | 154.75% | 0.95x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
NNOX
Nano-X Imaging Ltd.
|
-$3M | -$14.2M | -31.33% | -32.75% | -412.88% | -$13.9M |
|
ICCM
IceCure Medical Ltd.
|
$277K | -$3.8M | -195.32% | -217.45% | -451.29% | -$3.1M |
|
INBS
Intelligent Bio Solutions, Inc.
|
$214.9K | -$2.9M | -213.68% | -255.54% | -263.64% | -$2.9M |
|
LAB
Standard BioTools, Inc.
|
$9.5M | -$23.5M | -22.34% | -24.44% | -120.02% | -$23.1M |
|
LNSR
LENSAR, Inc.
|
$5.8M | -$7.6M | -684.94% | -1013.45% | -52.95% | -$3.5M |
|
XYLO
Xylo Technologies Ltd.
|
-- | -- | -40.15% | -51.7% | -- | -- |
Nano-X Imaging Ltd. vs. Competitors
-
Which has Higher Returns NNOX or ICCM?
IceCure Medical Ltd. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of -454%. Nano-X Imaging Ltd.'s return on equity of -32.75% beat IceCure Medical Ltd.'s return on equity of -217.45%.
Company Gross Margin Earnings Per Share Invested Capital NNOXNano-X Imaging Ltd.-86.42% -$0.21 $164.6M ICCMIceCure Medical Ltd.32.59% -$0.06 $9.6M -
What do Analysts Say About NNOX or ICCM?
Nano-X Imaging Ltd. has a consensus price target of $8.15, signalling upside risk potential of 184.97%. On the other hand IceCure Medical Ltd. has an analysts' consensus of $3.13 which suggests that it could grow by 370.21%. Given that IceCure Medical Ltd. has higher upside potential than Nano-X Imaging Ltd., analysts believe IceCure Medical Ltd. is more attractive than Nano-X Imaging Ltd..
Company Buy Ratings Hold Ratings Sell Ratings NNOXNano-X Imaging Ltd.4 0 0 ICCMIceCure Medical Ltd.1 0 0 -
Is NNOX or ICCM More Risky?
Nano-X Imaging Ltd. has a beta of 1.070, which suggesting that the stock is 6.959% more volatile than S&P 500. In comparison IceCure Medical Ltd. has a beta of 0.997, suggesting its less volatile than the S&P 500 by 0.34999999999999%.
-
Which is a Better Dividend Stock NNOX or ICCM?
Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IceCure Medical Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. IceCure Medical Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NNOX or ICCM?
Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are larger than IceCure Medical Ltd. quarterly revenues of $850K. Nano-X Imaging Ltd.'s net income of -$13.7M is lower than IceCure Medical Ltd.'s net income of -$3.9M. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while IceCure Medical Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 14.66x versus 13.44x for IceCure Medical Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NNOXNano-X Imaging Ltd.14.66x -- $3.4M -$13.7M ICCMIceCure Medical Ltd.13.44x -- $850K -$3.9M
-
Which has Higher Returns NNOX or INBS?
Intelligent Bio Solutions, Inc. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of -269.38%. Nano-X Imaging Ltd.'s return on equity of -32.75% beat Intelligent Bio Solutions, Inc.'s return on equity of -255.54%.
Company Gross Margin Earnings Per Share Invested Capital NNOXNano-X Imaging Ltd.-86.42% -$0.21 $164.6M INBSIntelligent Bio Solutions, Inc.19.33% -$0.35 $5.4M -
What do Analysts Say About NNOX or INBS?
Nano-X Imaging Ltd. has a consensus price target of $8.15, signalling upside risk potential of 184.97%. On the other hand Intelligent Bio Solutions, Inc. has an analysts' consensus of -- which suggests that it could grow by 2379.34%. Given that Intelligent Bio Solutions, Inc. has higher upside potential than Nano-X Imaging Ltd., analysts believe Intelligent Bio Solutions, Inc. is more attractive than Nano-X Imaging Ltd..
Company Buy Ratings Hold Ratings Sell Ratings NNOXNano-X Imaging Ltd.4 0 0 INBSIntelligent Bio Solutions, Inc.0 0 0 -
Is NNOX or INBS More Risky?
Nano-X Imaging Ltd. has a beta of 1.070, which suggesting that the stock is 6.959% more volatile than S&P 500. In comparison Intelligent Bio Solutions, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock NNOX or INBS?
Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intelligent Bio Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. Intelligent Bio Solutions, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NNOX or INBS?
Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are larger than Intelligent Bio Solutions, Inc. quarterly revenues of $1.1M. Nano-X Imaging Ltd.'s net income of -$13.7M is lower than Intelligent Bio Solutions, Inc.'s net income of -$3M. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while Intelligent Bio Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 14.66x versus 9.62x for Intelligent Bio Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NNOXNano-X Imaging Ltd.14.66x -- $3.4M -$13.7M INBSIntelligent Bio Solutions, Inc.9.62x -- $1.1M -$3M
-
Which has Higher Returns NNOX or LAB?
Standard BioTools, Inc. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of -162.05%. Nano-X Imaging Ltd.'s return on equity of -32.75% beat Standard BioTools, Inc.'s return on equity of -24.44%.
Company Gross Margin Earnings Per Share Invested Capital NNOXNano-X Imaging Ltd.-86.42% -$0.21 $164.6M LABStandard BioTools, Inc.48.51% -$0.09 $427M -
What do Analysts Say About NNOX or LAB?
Nano-X Imaging Ltd. has a consensus price target of $8.15, signalling upside risk potential of 184.97%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.65 which suggests that it could grow by 12.32%. Given that Nano-X Imaging Ltd. has higher upside potential than Standard BioTools, Inc., analysts believe Nano-X Imaging Ltd. is more attractive than Standard BioTools, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NNOXNano-X Imaging Ltd.4 0 0 LABStandard BioTools, Inc.1 2 0 -
Is NNOX or LAB More Risky?
Nano-X Imaging Ltd. has a beta of 1.070, which suggesting that the stock is 6.959% more volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.236, suggesting its more volatile than the S&P 500 by 23.585%.
-
Which is a Better Dividend Stock NNOX or LAB?
Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NNOX or LAB?
Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are smaller than Standard BioTools, Inc. quarterly revenues of $19.6M. Nano-X Imaging Ltd.'s net income of -$13.7M is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 14.66x versus 4.06x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NNOXNano-X Imaging Ltd.14.66x -- $3.4M -$13.7M LABStandard BioTools, Inc.4.06x -- $19.6M -$31.7M
-
Which has Higher Returns NNOX or LNSR?
LENSAR, Inc. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of -25.94%. Nano-X Imaging Ltd.'s return on equity of -32.75% beat LENSAR, Inc.'s return on equity of -1013.45%.
Company Gross Margin Earnings Per Share Invested Capital NNOXNano-X Imaging Ltd.-86.42% -$0.21 $164.6M LNSRLENSAR, Inc.40.56% -$0.31 -$9.2M -
What do Analysts Say About NNOX or LNSR?
Nano-X Imaging Ltd. has a consensus price target of $8.15, signalling upside risk potential of 184.97%. On the other hand LENSAR, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 25.52%. Given that Nano-X Imaging Ltd. has higher upside potential than LENSAR, Inc., analysts believe Nano-X Imaging Ltd. is more attractive than LENSAR, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NNOXNano-X Imaging Ltd.4 0 0 LNSRLENSAR, Inc.0 2 0 -
Is NNOX or LNSR More Risky?
Nano-X Imaging Ltd. has a beta of 1.070, which suggesting that the stock is 6.959% more volatile than S&P 500. In comparison LENSAR, Inc. has a beta of 0.665, suggesting its less volatile than the S&P 500 by 33.53%.
-
Which is a Better Dividend Stock NNOX or LNSR?
Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. LENSAR, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NNOX or LNSR?
Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are smaller than LENSAR, Inc. quarterly revenues of $14.3M. Nano-X Imaging Ltd.'s net income of -$13.7M is lower than LENSAR, Inc.'s net income of -$3.7M. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while LENSAR, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 14.66x versus 2.39x for LENSAR, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NNOXNano-X Imaging Ltd.14.66x -- $3.4M -$13.7M LNSRLENSAR, Inc.2.39x -- $14.3M -$3.7M
-
Which has Higher Returns NNOX or XYLO?
Xylo Technologies Ltd. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of --. Nano-X Imaging Ltd.'s return on equity of -32.75% beat Xylo Technologies Ltd.'s return on equity of -51.7%.
Company Gross Margin Earnings Per Share Invested Capital NNOXNano-X Imaging Ltd.-86.42% -$0.21 $164.6M XYLOXylo Technologies Ltd.-- -- $22.4M -
What do Analysts Say About NNOX or XYLO?
Nano-X Imaging Ltd. has a consensus price target of $8.15, signalling upside risk potential of 184.97%. On the other hand Xylo Technologies Ltd. has an analysts' consensus of $9.00 which suggests that it could grow by 77.52%. Given that Nano-X Imaging Ltd. has higher upside potential than Xylo Technologies Ltd., analysts believe Nano-X Imaging Ltd. is more attractive than Xylo Technologies Ltd..
Company Buy Ratings Hold Ratings Sell Ratings NNOXNano-X Imaging Ltd.4 0 0 XYLOXylo Technologies Ltd.1 0 0 -
Is NNOX or XYLO More Risky?
Nano-X Imaging Ltd. has a beta of 1.070, which suggesting that the stock is 6.959% more volatile than S&P 500. In comparison Xylo Technologies Ltd. has a beta of 0.148, suggesting its less volatile than the S&P 500 by 85.241%.
-
Which is a Better Dividend Stock NNOX or XYLO?
Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xylo Technologies Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $3.94 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. Xylo Technologies Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NNOX or XYLO?
Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are larger than Xylo Technologies Ltd. quarterly revenues of --. Nano-X Imaging Ltd.'s net income of -$13.7M is higher than Xylo Technologies Ltd.'s net income of --. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while Xylo Technologies Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 14.66x versus 0.13x for Xylo Technologies Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NNOXNano-X Imaging Ltd.14.66x -- $3.4M -$13.7M XYLOXylo Technologies Ltd.0.13x -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
